每经头条（nbdtoutiao）——"野生"带玩管家出没迪士尼，从日赚上千卷到350元！专家看到的却是500 亿元"陪伴经济"…… 每经AI快讯，浙江震元（SZ 000705，收盘价：9.57元）11月28日晚间发布公告称，公司第十一届董事 会2025年第五次临时会议于2025年11月28日以通讯形式召开。会议审议了《关于修订部分上市公司制度 的议案》等文件。 （记者 曾健辉） 2025年1至6月份，浙江震元的营业收入构成为：商业占比77.73%，工业-医药制造占比22.27%。 截至发稿，浙江震元市值为32亿元。 ...

（编辑 任世碧） 证券日报网讯 11月28日晚间，国药一致发布公告称，公司董事会于近日收到公司副总经理陈常兵先生 的书面辞任报告。陈常兵先生因工作调整原因，申请辞去公司副总经理职务，辞任后仍在公司担任其他 职务。 ...

每经AI快讯，东北制药（SZ 000597，收盘价：5.59元）11月28日晚间发布公告称，公司第十届第八次 董事会会议于2025年11月28日以通讯表决的方式召开。会议审议了《关于会计估计变更的议案》等文 件。 （记者 王晓波） 2025年1至6月份，东北制药的营业收入构成为：医药制造业占比52.0%，医药商业占比46.18%，其他行 业占比1.82%。 截至发稿，东北制药市值为80亿元。 每经头条（nbdtoutiao）——已有75人遇难，1名死者为消防员，还有10名消防员受伤！记者现场直击香 港大埔火灾：燃烧的宏福苑，五级大火的五个谜团 ...

【重药控股22家下属公司补缴税款4430.26万元】11月28日，重药控股（000950.SZ）披露下属22家公司 合计补缴前期所享受的西部大开发企业所得税优惠税款及滞纳金总计4430.26万元。 公告显示，重药控股下属子公司重庆医药新特药品有限公司、重庆医药集团医贸药品有限公司、重庆医 药集团药特分有限责任公司、重庆医药集团医疗器械有限公司、重庆医药（集团）股份有限公司、重庆 医药集团陕西有限公司、重庆医药和平医药新产品有限公司、重庆医药集团（宁夏）有限公司、和平泰 康资阳药业有限责任公司、重庆医药上海药品销售有限责任公司、重庆医药集团铭维医疗器械有限公 司、重庆和平吉隆医疗器械有限公司、重庆医药互诚科技有限公司、重庆医药集团绵阳医药有限公司、 重庆医药集团供应链管理有限公司、重庆医药合川医药有限责任公司、重庆医药西南生物新药有限责任 公司、重药控股（宁夏）医药有限公司、重药控股贵州医疗有限公司、重庆医药集团江津医药有限公 司、重药天泽（重庆）医疗器械有限公司、重庆医药天昊医药有限公司，共计22家单位根据各自主管税 务部门的通知，经自查需补缴前期所享受的西部大开发企业所得税优惠税款及滞纳金总计4430.26 ...

每经头条（nbdtoutiao）——已有75人遇难，1名死者为消防员，还有10名消防员受伤！记者现场直击香 港大埔火灾：燃烧的宏福苑，五级大火的五个谜团 （记者 王晓波） 2025年1至6月份，人民同泰的营业收入构成为：医药商业批发-医疗客户占比57.85%，医药商业批发-商 业客户占比22.14%，医药商业零售占比18.91%，其他占比0.69%，出租固定资产占比0.2%。 截至发稿，人民同泰市值为73亿元。 每经AI快讯，人民同泰（SH 600829，收盘价：12.67元）11月28日晚间发布公告称，公司董事会同意聘 任曲睿女士为公司证券事务代表，协助董事会秘书履行职责，任期与第十一届董事会任期一致。 ...

从资金流向上来看，当日医药商业板块主力资金净流出2.28亿元，游资资金净流出2472.38万元，散户资 金净流入2.52亿元。医药商业板块个股资金流向见下表： 证券之星消息，11月28日医药商业板块较上一交易日上涨0.29%，海王生物领涨。当日上证指数报收于 3888.6，上涨0.34%。深证成指报收于12984.08，上涨0.85%。医药商业板块个股涨跌见下表： | 代码 | 名称 | 收盘价 | 涨跌幅 | 成交量(手) | 成交额(元) | | --- | --- | --- | --- | --- | --- | | 000078 | 海壬生物 | 3.40 | 10.03% | 410.67万 | 13.33 Z | | 603122 | 合富中国 | 23.82 | 7.49% | 108.60万 | 24.53亿 | | 600538 | 国发股份 | 6.45 | 2.06% | 14.97万 | 9550.39万 | | 301126 | 达嘉维康 | 12.83 | 0.94% | 11.65万 | 1.50亿 | | 000411 | 英特集团 | 12.04 | 0.92% | 13. ...

Group 1 - The core point of the article is the resignation of Mr. Chen Changbing from the position of Deputy General Manager of China National Pharmaceutical Group Corporation (国药一致), effective immediately upon submission of his resignation report to the board, while he will continue to hold other positions within the company [1] - For the first half of 2025, the revenue composition of China National Pharmaceutical Group Corporation is as follows: 70.21% from pharmaceutical wholesale, 29.28% from pharmaceutical retail, and 0.51% from other products [1] - As of the time of reporting, the market capitalization of China National Pharmaceutical Group Corporation is 13.8 billion yuan [1]

Market Performance - The three major A-share indices collectively declined in November, with the Shanghai Composite Index falling by 1.67% to close at 3888 points, ending a six-month streak of gains [1] - The Shenzhen Component Index dropped by 2.95% to 12984 points, while the ChiNext Index decreased by 4.23% to 3052 points, marking the second consecutive month of decline for both indices [1] - The North Star 50 Index experienced a significant drop of 12.32% to 1387 points, and the Sci-Tech Innovation 50 Index fell by 6.24% to 1327 points [1] Sector Performance - The top five performing sectors over the past 20 trading days included: - Pharmaceutical Commerce up by 6.65% - Education up by 5.1% - Petroleum Processing and Trade up by 4.83% - Cultural Media up by 4.71% - Apparel and Home Textiles up by 4.5% [1] - Conversely, the bottom five sectors were: - Securities down by 6.16% - Electrical Machinery down by 5.85% - Automation Equipment down by 5.33% - Automotive Parts down by 5.07% - Medical Services down by 4.58% [1] Individual Stock Performance - The top five individual stocks in terms of gains for November were: - Dapeng Industrial up by 553.33% - Danna Biotechnology up by 378.07% - South Network Digital up by 334.45% - Beikong Detection up by 264.63% - Hengkun New Materials up by 228.29% [1] - The bottom five individual stocks in terms of losses were: - Heyuan Biotechnology down by 36.06% - *ST Changyao down by 31.96% - Huide Technology down by 31.47% - Degute down by 29.26% - Bangji Technology down by 26.96% [1]

11月28日，重药控股（000950.SZ）披露下属22家公司合计补缴前期所享受的西部大开发企业所得税优 惠税款及滞纳金总计4430.26万元。 公告显示，重药控股下属子公司重庆医药新特药品有限公司、重庆医药集团医贸药品有限公司、重庆医 药集团药特分有限责任公司、重庆医药集团医疗器械有限公司、重庆医药（集团）股份有限公司、重庆 医药集团陕西有限公司、重庆医药和平医药新产品有限公司、重庆医药集团（宁夏）有限公司、和平泰 康资阳药业有限责任公司、重庆医药上海药品销售有限责任公司、重庆医药集团铭维医疗器械有限公 司、重庆和平吉隆医疗器械有限公司、重庆医药互诚科技有限公司、重庆医药集团绵阳医药有限公司、 重庆医药集团供应链管理有限公司、重庆医药合川医药有限责任公司、重庆医药西南生物新药有限责任 公司、重药控股（宁夏）医药有限公司、重药控股贵州医疗有限公司、重庆医药集团江津医药有限公 司、重药天泽（重庆）医疗器械有限公司、重庆医药天昊医药有限公司，共计22家单位根据各自主管税 务部门的通知，经自查需补缴前期所享受的西部大开发企业所得税优惠税款及滞纳金总计4430.26万 元。上述税款及滞纳金已全部缴纳完毕，主管税务部门 ...

1. Report Industry Investment Rating - There is no information about the report industry investment rating in the provided content. 2. Core Viewpoints of the Report - The inter - bank market liquidity remains loose, with the overnight repurchase rate of deposit - taking institutions staying around 1.32%. The November LPR quotes remain unchanged [4]. - The stock index rose and then fell yesterday, showing an overall volatile performance. It is expected that market differences will be gradually digested during the stock index's volatile adjustment, and the index is expected to rise further with the emergence of new mainlines. The bottom - fishing effect of Central Huijin provides a certain buffer, and the downside risk of the index is generally controllable. The recent market adjustment offers an opportunity to lay out for the further rise of the stock index next year [6]. 3. Summary According to Relevant Catalogs 3.1 Macro - financial Data - **Interest Rates**: DR001 closed at 1.31%, down 0.04bp; DR007 at 1.45%, down 2.79bp; GC001 at 1.38%, down 6.50bp; GC007 at 1.52%, down 1.00bp; SHBOR 3M at 1.58%, up 0.10bp; LPR 5 - year at 3.50%, unchanged; 1 - year treasury bond at 1.35%, down 0.60bp; 5 - year treasury bond at 1.57%, up 0.20bp; 10 - year treasury bond at 1.84%, down 0.10bp; 10 - year US treasury bond at 4.00%, down 1.00bp [3]. - **Central Bank Operations**: The central bank conducted 356.4 billion yuan of 7 - day reverse repurchase operations yesterday at an operating rate of 1.40%. With 300 billion yuan of reverse repurchases maturing on the same day, the net investment for the day was 56.4 billion yuan [3]. 3.2 Stock Index Market - **Closing Prices and Changes**: The CSI 300 closed at 4515, down 0.05%; the SSE 50 at 2972, up 0.02%; the CSI 500 at 6951.3, down 0.2%; the CSI 1000 at 7257.5, up 0.12%. The trading volume of the two stock markets in Shanghai and Shenzhen was 1.7098 trillion yuan, a decrease of 73.6 billion yuan from the previous day. Industry sectors showed mixed performance, with papermaking, batteries, consumer electronics, photovoltaic equipment, and chemical raw materials sectors leading the gains, while cultural media, cement building materials, Internet services, pharmaceutical commerce, and gaming sectors leading the losses [5]. - **Futures Contracts**: IF volume was 100,893, up 3.7%; IF open interest was 264,196, up 1.9%; IH volume was 42,497, up 19.7%; IH open interest was 92,285, up 7.0%; IC volume was 112,976, up 5.6%; IC open interest was 254,570, up 2.2%; IM volume was 183,443, up 3.3%; IM open interest was 364,043, up 0.8% [5]. 3.3 Futures Contract Premium and Discount - **IF**: The premium/discount rates for the current - month, next - month, current - quarter, and next - quarter contracts were 8.38%, 6.21%, 3.95%, and 3.99% respectively [7]. - **IH**: The premium/discount rates for the current - month, next - month, current - quarter, and next - quarter contracts were 5.51%, 3.70%, 1.81%, and 1.63% respectively [7]. - **IC**: The premium/discount rates for the current - month, next - month, current - quarter, and next - quarter contracts were 13.15%, 11.90%, 10.34%, and 11.10% respectively [7]. - **IM**: The premium/discount rates for the current - month, next - month, current - quarter, and next - quarter contracts were 17.93%, 15.48%, 13.47%, and 13.25% respectively [7].